214 related articles for article (PubMed ID: 31112526)
21. Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells.
Wang L; Liu Z; Balivada S; Shrestha T; Bossmann S; Pyle M; Pappan L; Shi J; Troyer D
Stem Cell Res Ther; 2012 Feb; 3(1):5. PubMed ID: 22330721
[TBL] [Abstract][Full Text] [Related]
22. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
[TBL] [Abstract][Full Text] [Related]
23. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
[TBL] [Abstract][Full Text] [Related]
25. Alpinetin targets glioma stem cells by suppressing Notch pathway.
Wang J; Yan Z; Liu X; Che S; Wang C; Yao W
Tumour Biol; 2016 Jul; 37(7):9243-8. PubMed ID: 26768745
[TBL] [Abstract][Full Text] [Related]
26. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
27. Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.
Luwor R; Morokoff AP; Amiridis S; D'Abaco G; Paradiso L; Stylli SS; Nguyen HPT; Tarleton M; Young KA; O'Brien TJ; Robinson PJ; Chircop M; McCluskey A; Jones NC
Cancer Invest; 2019; 37(3):144-155. PubMed ID: 30907150
[TBL] [Abstract][Full Text] [Related]
28. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
29. Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.
Sun T; Li Y; Huang Y; Zhang Z; Yang W; Du Z; Zhou Y
Oncotarget; 2016 Jul; 7(28):43095-43108. PubMed ID: 27191269
[TBL] [Abstract][Full Text] [Related]
30. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
31. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
Li GH; Wei H; Lv SQ; Ji H; Wang DL
Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
[TBL] [Abstract][Full Text] [Related]
33. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
[TBL] [Abstract][Full Text] [Related]
35. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
[TBL] [Abstract][Full Text] [Related]
36. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
[TBL] [Abstract][Full Text] [Related]
37. Glioma stem-like cells are less susceptible than glioma cells to sonodynamic therapy with photofrin.
Xu ZY; Li XQ; Chen S; Cheng Y; Deng JM; Wang ZG
Technol Cancer Res Treat; 2012 Dec; 11(6):615-23. PubMed ID: 22775340
[TBL] [Abstract][Full Text] [Related]
38. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
39. Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells.
Hyun KH; Yoon CH; Kim RK; Lim EJ; An S; Park MJ; Hyun JW; Suh Y; Kim MJ; Lee SJ
Toxicol Appl Pharmacol; 2011 Jul; 254(1):32-40. PubMed ID: 21514314
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
